Expert panel assessment of acute liver injury identification in observational data
Authors:
- Richard A. HansenRHRichard A. Hansen
- Michael D. GrayMGMichael D. Gray
- Brent I. FoxBFBrent I. Fox
- Joshua C. HollingsworthJHJoshua C. Hollingsworth
- Juan GaoJGJuan Gao
- Michael L. HollingsworthMHMichael L. Hollingsworth
- David Mark CarpenterDCDavid Mark Carpenter
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Research in Social and Administrative Pharmacy
- Vol. 10 (1) , 156-167
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes PartnershipStatistics in Medicine, 2012
- Advancing the Science for Active Surveillance: Rationale and Design for the Observational Medical Outcomes PartnershipAnnals of Internal Medicine, 2010
- Adverse Drug Reactions in Hospital and Ambulatory Care Settings Identified Using a Large Administrative DatabaseAnnals of Pharmacotherapy, 2010
- Drug-versus-Drug Adverse Event Rate ComparisonsDrug Safety, 2009
- Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clinical Pharmacology, 2007
- Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective studyBMC Clinical Pharmacology, 2007
- Evaluation of Serious Adverse Drug ReactionsArchives of internal medicine (1960), 2007
- Drug-Related Morbidity and Mortality: Updating the Cost-of-Illness ModelJournal of the American Pharmaceutical Association, 2001
- Frequency and cost of serious adverse drug reactions in a department of general medicineBritish Journal of Clinical Pharmacology, 1998
- Adverse drug reaction monitoring—cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissionsPharmacoepidemiology and Drug Safety, 1997